BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10406494)

  • 1. AGE accumulation in peritoneal membrane and cavity during peritoneal dialysis and its effect on peritoneal structure and function.
    Park MS; Lee HB
    Perit Dial Int; 1999; 19 Suppl 2():S53-7. PubMed ID: 10406494
    [No Abstract]   [Full Text] [Related]  

  • 2. Peritoneal transport in long-term peritoneal dialysis patients and its relation with AGEs.
    Feriani M
    Contrib Nephrol; 2001; (131):74-81. PubMed ID: 11125565
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategy for preventing peritoneal dialysis failure.
    Cancarini G
    Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
    [No Abstract]   [Full Text] [Related]  

  • 4. The dialytic failure of the peritoneal membrane.
    Lupo A; Rugiu C; Lapolla A; Maiorca P; Aricó CN; Bernich P; Marcantoni C; Brezzi B; Maschio G
    Contrib Nephrol; 2001; (131):90-6. PubMed ID: 11125567
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
    Park MS; Kim JK; Holmes C; Weiss MF
    Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions.
    Krediet RT
    Int J Artif Organs; 1998 Aug; 21(8):437-9. PubMed ID: 9803343
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
    Dawnay AB; Millar DJ
    Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycosylation end products in peritoneal tissue with different solutions.
    Dobbie JW
    Perit Dial Int; 1997; 17 Suppl 2():S27-30. PubMed ID: 9163793
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical research in peritoneal dialysis.
    Coles GA
    Contrib Nephrol; 2001; (131):125-31. PubMed ID: 11125558
    [No Abstract]   [Full Text] [Related]  

  • 10. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients.
    Nakamoto H; Hamada C; Shimaoka T; Sekiguchi Y; Io H; Kaneko K; Horikoshi S; Tomino Y
    J Artif Organs; 2014 Mar; 17(1):60-8. PubMed ID: 24337623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic significance of reduced levels of glucose degradation products.
    Rippe B; Wieslander A
    Perit Dial Int; 2001; 21 Suppl 3():S114-8. PubMed ID: 11887804
    [No Abstract]   [Full Text] [Related]  

  • 13. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of the peritoneal membrane: in between morphology and function.
    Anglani F; Forino M; Del Prete D; Ceol M; Favaro S
    Contrib Nephrol; 2001; (131):61-73. PubMed ID: 11125564
    [No Abstract]   [Full Text] [Related]  

  • 15. The breakdown of preformed peritoneal advanced glycation end products by intraperitoneal alagebrium.
    Lee YK; Lee JY; Kim JS; Won KB; Kang HJ; Jang TJ; Tak WT; Lee JH
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S189-94. PubMed ID: 19194551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.
    Honda K; Nitta K; Horita S; Yumura W; Nihei H; Nagai R; Ikeda K; Horiuchi S
    Nephrol Dial Transplant; 1999 Jun; 14(6):1541-9. PubMed ID: 10383022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactate-buffered and bicarbonate-buffered solutions with less glucose degradation products in a two-chamber system.
    Passlick-Deetjen J; Lage C
    Perit Dial Int; 2000; 20 Suppl 2():S42-7. PubMed ID: 10911642
    [No Abstract]   [Full Text] [Related]  

  • 18. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients.
    Mahiout A; Ehlerding G; Brunkhorst R
    Nephrol Dial Transplant; 1996; 11 Suppl 5():2-6. PubMed ID: 9044298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal accumulation of AGE and peritoneal membrane permeability.
    Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
    Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-products and peritoneal sclerosis.
    Nakamura S; Niwa T
    Semin Nephrol; 2004 Sep; 24(5):502-5. PubMed ID: 15490420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.